This article is more than 5 years old. Information may no longer be current.

VIDEO: AI-based diabetic retinopathy screening device shows ‘exceptional results’

ByKaushal Solanki, PhD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VANCOUVER, British Columbia — Kaushal Solanki, PhD, founder and CEO of Eyenuk Inc., discusses study results of the EyeArt AI Screening System for autonomous detection of diabetic retinopathy at the Association for Research in Vision and Ophthalmology meeting.

The prospective, multicenter, pivotal clinical trial found “exceptional results,” according to Solanki.